ABRAXANE APPROVED FOR ADVANCED BREAST CANCER TREATMENT IN CANADA

Abraxis Oncology announced that it has received Health Canada approval for ABRAXANE for the treatment of metastatic breast cancer, including previously untreated metastatic disease. ABRAXANE, a unique new cancer therapy, is now commercially available. CNW Group (http://www.newswire.ca/en/releases/archive/September2006/13/c5473.html)